InvestorsObserver
×
News Home

Is Athira Pharma Inc (ATHA) a Good Buy in the Biotechnology Industry?

Monday, March 11, 2024 10:48 AM | InvestorsObserver Analysts

Mentioned in this article

Is Athira Pharma Inc (ATHA) a Good Buy in the Biotechnology Industry?

A rating of 83 puts Athira Pharma Inc (ATHA) near the top of the Biotechnology industry according to InvestorsObserver. Athira Pharma Inc's score of 83 means it scores higher than 83% of stocks in the industry. Athira Pharma Inc also received an overall rating of 71, putting it above 71% of all stocks. Biotechnology is ranked 18 out of the 148 industries.

Overall Score - 71
ATHA has an Overall Score of 71. Find out what this means to you and get the rest of the rankings on ATHA!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 71 means the stock is more attractive than 71 percent of stocks.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Athira Pharma Inc Stock Today?

Athira Pharma Inc (ATHA) stock is trading at $3.14 as of 10:34 AM on Monday, Mar 11, a drop of -$0.44, or -12.29% from the previous closing price of $3.58. The stock has traded between $3.08 and $3.64 so far today. Volume today is below average. So far 200,204 shares have traded compared to average volume of 346,534 shares. Click Here to get the full Stock Report for Athira Pharma Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App